Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., confirming regulatory approval of an upda…
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., updating the approval status for this generic…
-
CLINICAL_TRIALS trial_result · 2007-04-11Clinical Trial Update: The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension [Phase 3]
A Phase 3 trial assessing whether frequent self-measurement of blood pressure improves control of hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-04Clinical Trial Update: Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness [Phase 4]
Phase 4 trial evaluating the effect of continuous positive airway pressure on hypertension and cardiovascular morbidity and mortality in sle…
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for furosemide (a generic diuretic) under the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., approving regulatory action on an existing generic…
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., resulting in changes to the product labeling…
-
CLINICAL_TRIALS trial_result · 2007-03-23Clinical Trial Update: The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism [Phase 4]
Clinical trial update reports the therapeutic effect of bromocriptine in patients with primary aldosteronism and associated hypertension (Ph…
-
CLINICAL_TRIALS trial_result · 2007-03-20Clinical Trial Update: Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects [Phase 3]
Phase 3 dose-ranging study evaluating the safety and tolerability of TOPROL-XL Extended-Release tablets in pediatric hypertension has comple…
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Nitrate and Hypertension in Heart Transplanted Patients [Phase 4]
Phase 4 clinical trial update examining nitrate therapy and blood pressure control in heart transplant patients.
-
FDA approval · 2007-03-16FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Leading Pharma, LLC)
FDA approved hydrochlorothiazide under Leading Pharma, LLC's original application (ANDA) for use as a diuretic to treat hypertension and ede…
-
FDA label_change · 2007-03-14FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC.
-
FDA approval · 2007-03-09FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Solco Healthcare LLC)
FDA approved Solco Healthcare LLC's clonidine hydrochloride under an Original Abbreviated New Drug Application (ANDA).
-
CLINICAL_TRIALS research · 2007-03-07Clinical Trial Update: Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
Assesses the diagnostic performance of the aldosterone-to-renin ratio for identifying primary aldosteronism in hypertensive individuals.
-
CLINICAL_TRIALS trial_result · 2007-03-06Clinical Trial Update: Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension [Phase 3]
Phase 3 trial comparing S-Amlodipine Gentisate to Amlodipine Besylate for mild-to-moderate hypertension has completed, evaluating efficacy a…
-
FDA approval · 2007-03-05FDA Approved: ALISKIREN — Original Application (Prasco Laboratories)
FDA approved Prasco Laboratories' original application for aliskiren hemifumarate, a direct renin inhibitor, for the treatment of hypertensi…
-
FDA approval · 2007-03-01FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under an ANDA. The action approves changes to the g…
-
FDA approval · 2007-02-27FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for MICARDIS HCT (telmisartan and hydrochlorothiazide) from Boehringer Ingelheim Pharmaceuticals, In…
-
FDA approval · 2007-02-27FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for MICARDIS (telmisartan) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Women's Use of Alternative Medicine: A Multiethnic Study
This update reports the completion of a multiethnic clinical trial on women's use of alternative medicine, sponsored by the NCCIH. It addres…
-
FDA approval · 2007-02-27FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic hydrochlorothiazide under an original ANDA from Actavis Pharma, Inc.
-
FDA approval · 2007-02-23FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
FDA label_change · 2007-02-21FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc., resulting in labe…
-
FDA approval · 2007-02-13FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA supplemental approval for Camber Pharmaceuticals' lisinopril generic under ANDA075903. Lisinopril is used to treat hypertension, heart f…
-
FDA approval · 2007-02-06FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide fixed-dose combination from Aurobindo Pharma Limited.